|
1
|
Irani K: Oxidant signaling in vascular
cell growth, death, and survival: A review of the roles of reactive
oxygen species in smooth muscle and endothelial cell mitogenic and
apoptotic signaling. Circ Res. 87:179–183. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perez-Vizcaino F, Cogolludo A and Moreno
L: Reactive oxygen species signaling in pulmonary vascular smooth
muscle. Respir Physiol Neurobiol. 174:212–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: A radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zelko IN, Mariani TJ and Folz RJ:
Superoxide dismutase multigene family: A comparison of the CuZn-SOD
(SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures,
evolution, and expression. Free Radic Biol Med. 33:337–349. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilcox CS: Reactive oxygen species: Roles
in blood pressure and kidney function. Curr Hypertens Rep.
4:160–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Collet JF and Messens J: Structure,
function, and mechanism of thioredoxin proteins. Antioxid Redox
Signal. 13:1205–1216. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH
and Cho JY: Thioredoxin and thioredoxin-interacting protein as
prognostic markers for gastric cancer recurrence. World J
Gastroenterol. 18:5581–5588. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pramanik KC and Srivastava SK: Apoptosis
signal-regulating kinase 1-thioredoxin complex dissociation by
capsaicin causes pancreatic tumor growth suppression by inducing
apoptosis. Antioxid Redox Signal. 17:1417–1432. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dunn LL, Buckle AM, Cooke JP and Ng MK:
The emerging role of the thioredoxin system in angiogenesis.
Arterioscler Thromb Vasc Biol. 30:2089–2098. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tipple TE: The thioredoxin system in
neonatal lung disease. Antioxid Redox Signal. 21:1916–1925. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu J, Li T, Wu H and Xu T: Role of
thioredoxin in lung disease. Pulm Pharmacol Ther. 25:154–162. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakamura T, Nakamura H, Hoshino T, Ueda S,
Wada H and Yodoi J: Redox regulation of lung inflammation by
thioredoxin. Antioxid Redox Signal. 7:60–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Galmarini CM: Drug evaluation: The
thioredoxin inhibitor PX-12 in the treatment of cancer. Curr Opin
Investig Drugs. 7:1108–1115. 2006.PubMed/NCBI
|
|
14
|
May HC, Yu JJ, Guentzel MN, Chambers JP,
Cap AP and Arulanandam BP: Repurposing Auranofin, Ebselen, and
PX-12 as antimicrobial agents targeting the thioredoxin system.
Front Microbiol. 9:3362018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wondrak GT: Redox-directed cancer
therapeutics: Molecular mechanisms and opportunities. Antioxid
Redox Signal. 11:3013–3069. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
You BR, Shin HR, Han BR and Park WH: PX-12
induces apoptosis in Calu-6 cells in an oxidative stress-dependent
manner. Tumour Biol. 36:2087–2095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
You BR, Shin HR and Park WH: PX-12
inhibits the growth of A549 lung cancer cells via G2/M phase arrest
and ROS-dependent apoptosis. Int J Oncol. 44:301–308. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shin HR, You BR and Park WH: PX-12-induced
HeLa cell death is associated with oxidative stress and GSH
depletion. Oncol Lett. 6:1804–1810. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
You BR and Park WH: Auranofin induces
mesothelioma cell death through oxidative stress and GSH depletion.
Oncol Rep. 35:546–551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
You BR, Shin HR, Han BR, Kim SH and Park
WH: Auranofin induces apoptosis and necrosis in HeLa cells via
oxidative stress and glutathione depletion. Mol Med Rep.
11:1428–1434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khairul I, Wang QQ, Jiang YH, Wang C and
Naranmandura H: Metabolism, toxicity and anticancer activities of
arsenic compounds. Oncotarget. 8:23905–23926. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Waxman S and Anderson KC: History of the
development of arsenic derivatives in cancer therapy. Oncologist.
(6 Suppl 2):S3–S10. 2001. View Article : Google Scholar
|
|
23
|
Chou WC, Jie C, Kenedy AA, Jones RJ, Trush
MA and Dang CV: Role of NADPH oxidase in arsenic-induced reactive
oxygen species formation and cytotoxicity in myeloid leukemia
cells. Proc Natl Acad Sci USA. 101:4578–4583. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miller WH Jr, Schipper HM, Lee JS, Singer
J and Waxman S: Mechanisms of action of arsenic trioxide. Cancer
Res. 62:3893–3903. 2002.PubMed/NCBI
|
|
25
|
Park WH, Seol JG, Kim ES, Hyun JM, Jung
CW, Lee CC, Kim BK and Lee YY: Arsenic trioxide-mediated growth
inhibition in MC/CAR myeloma cells via cell cycle arrest in
association with induction of cyclin-dependent kinase inhibitor,
p21, and apoptosis. Cancer Res. 60:3065–3071. 2000.PubMed/NCBI
|
|
26
|
Zhang W, Liu Y, An Z, Huang D, Qi Y and
Zhang Y: Mediating effect of ROS on mtDNA damage and low ATP
content induced by arsenic trioxide in mouse oocytes. Toxicol In
Vitro. 25:979–984. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li JX, Shen YQ, Cai BZ, Zhao J, Bai X, Lu
YJ and Li XQ: Arsenic trioxide induces the apoptosis in vascular
smooth muscle cells via increasing intracellular calcium and ROS
formation. Mol Biol Rep. 37:1569–1576. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
You BR and Park WH: Arsenic trioxide
induces human pulmonary fibroblast cell death via increasing ROS
levels and GSH depletion. Oncol Rep. 28:749–757. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cha Y, Park DW, Lee CH, Baek SH, Kim SY,
Kim JR and Kim JH: Arsenic trioxide induces apoptosis in human
colorectal adenocarcinoma HT-29 cells through ROS. Cancer Res
Treat. 38:54–60. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu J, Chew EH and Holmgren A: Targeting
thioredoxin reductase is a basis for cancer therapy by arsenic
trioxide. Proc Natl Acad Sci USA. 104:12288–12293. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
States JC, Srivastava S, Chen Y and
Barchowsky A: Arsenic and cardiovascular disease. Toxicol Sci.
107:312–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rahman MM, Ng JC and Naidu R: Chronic
exposure of arsenic via drinking water and its adverse health
impacts on humans. Environ Geochem Health. 31 (Suppl 1):S189–S200.
2009. View Article : Google Scholar
|
|
33
|
Rahman M, Tondel M, Ahmad SA, Chowdhury
IA, Faruquee MH and Axelson O: Hypertension and arsenic exposure in
Bangladesh. Hypertension. 33:74–78. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tseng CH: Cardiovascular disease in
arsenic-exposed subjects living in the arseniasis-hyperendemic
areas in Taiwan. Atherosclerosis. 199:12–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Islam LN, Nabi AH, Rahman MM and Zahid MS:
Association of respiratory complications and elevated serum
immunoglobulins with drinking water arsenic toxicity in human. J
Environ Sci Health A Tox Hazard Subst Environ Eng. 42:1807–1814.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park WH, Han BR, Park HK and Kim SZ:
Arsenic trioxide induces growth inhibition and death in human
pulmonary artery smooth muscle cells accompanied by mitochondrial
O2•- increase and GSH depletion. Environ Toxicol. 2018. View Article : Google Scholar :
|
|
37
|
You BR and Park WH: Suberoylanilide
hydroxamic acid induces thioredoxin1-mediated apoptosis in lung
cancer cells via up-regulation of miR-129-5p. Mol Carcinog.
56:2566–2577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
You BR and Park WH: Down-regulation of
thioredoxin1 is involved in death of Calu-6 lung cancer cells
treated with suberoyl bishydroxamic acid. J Cell Biochem.
117:1250–1261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
You BR, Kim SH and Park WH: Reactive
oxygen species, glutathione, and thioredoxin influence suberoyl
bishydroxamic acid-induced apoptosis in A549 lung cancer cells.
Tumour Biol. 36:3429–3439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Park WH: Pyrogallol induces the death of
human pulmonary fibroblast cells through ROS increase and GSH
depletion. Int J Oncol. 49:785–792. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Berridge MV, Herst PM and Tan AS:
Tetrazolium dyes as tools in cell biology: New insights into their
cellular reduction. Biotechnol Annu Rev. 11:127–152. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Han YH, Kim SH, Kim SZ and Park WH:
Caspase inhibitor decreases apoptosis in pyrogallol-treated lung
cancer Calu-6 cells via the prevention of GSH depletion. Int J
Oncol. 33:1099–1105. 2008.PubMed/NCBI
|
|
43
|
Arnér ES and Holmgren A: The thioredoxin
system in cancer. Semin Cancer Biol. 16:420–426. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fernandes AP, Capitanio A, Selenius M,
Brodin O, Rundlöf AK and Björnstedt M: Expression profiles of
thioredoxin family proteins in human lung cancer tissue:
Correlation with proliferation and differentiation. Histopathology.
55:313–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sugiura H and Ichinose M: Oxidative and
nitrative stress in bronchial asthma. Antioxid Redox Signal.
10:785–797. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
You BR and Park WH: Suberoylanilide
hydroxamic acid-induced HeLa cell death is closely correlated with
oxidative stress and thioredoxin 1 levels. Int J Oncol.
44:1745–1755. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schenk H, Klein M, Erdbrügger W, Dröge W
and Schulze-Osthoff K: Distinct effects of thioredoxin and
antioxidants on the activation of transcription factors NF-kappa B
and AP-1. Proc Natl Acad Sci USA. 91:1672–1676. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hirota K, Murata M, Sachi Y, Nakamura H,
Takeuchi J, Mori K and Yodoi J: Distinct roles of thioredoxin in
the cytoplasm and in the nucleus. A two-step mechanism of redox
regulation of transcription factor NF-kappaB. J Biol Chem.
274:27891–27897. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bloomfield KL, Osborne SA, Kennedy DD,
Clarke FM and Tonissen KF: Thioredoxin-mediated redox control of
the transcription factor Sp1 and regulation of the thioredoxin gene
promoter. Gene. 319:107–116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Daloso DM, Müller K, Obata T, Florian A,
Tohge T, Bottcher A, Riondet C, Bariat L, Carrari F, Nunes-Nesi A,
et al: Thioredoxin, a master regulator of the tricarboxylic acid
cycle in plant mitochondria. Proc Natl Acad Sci USA.
112:E1392–E1400. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jin Y, Zhang X, Shu L, Chen L, Sun L, Qian
H, Liu W and Fu Z: Oxidative stress response and gene expression
with atrazine exposure in adult female zebrafish (Danio rerio).
Chemosphere. 78:846–852. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sarkar S, Mukherjee S, Chattopadhyay A and
Bhattacharya S: Differential modulation of cellular antioxidant
status in zebrafish liver and kidney exposed to low dose arsenic
trioxide. Ecotoxicol Environ Saf. 135:173–182. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kim HR, Kim EJ, Yang SH, Jeong ET, Park C,
Kim SJ, Youn MJ, So HS and Park R: Combination treatment with
arsenic trioxide and sulindac augments their apoptotic potential in
lung cancer cells through activation of caspase cascade and
mitochondrial dysfunction. Int J Oncol. 28:1401–1408.
2006.PubMed/NCBI
|
|
54
|
Sarkar S, Mukherjee S, Chattopadhyay A and
Bhattacharya S: Low dose of arsenic trioxide triggers oxidative
stress in zebrafish brain: Expression of antioxidant genes.
Ecotoxicol Environ Saf. 107:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Dai J, Weinberg RS, Waxman S and Jing Y:
Malignant cells can be sensitized to undergo growth inhibition and
apoptosis by arsenic trioxide through modulation of the glutathione
redox system. Blood. 93:268–277. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Han YH, Kim SZ, Kim SH and Park WH:
Induction of apoptosis in arsenic trioxide-treated lung cancer A549
cells by buthionine sulfoximine. Mol Cells. 26:158–164.
2008.PubMed/NCBI
|
|
57
|
Han YH, Kim SH, Kim SZ and Park WH:
Apoptosis in arsenic trioxide-treated Calu-6 lung cells is
correlated with the depletion of GSH levels rather than the changes
of ROS levels. J Cell Biochem. 104:862–878. 2008. View Article : Google Scholar : PubMed/NCBI
|
